|
Comparison of the Effects of MAT Pilates and MIHA Combined Exercise Programs on Pain, Quality of Life, Anxiety, and Endurance in Patients With Nonspecific Back Pain
RECRUITINGN/ASponsored by Istanbul Medipol University Hospital
Actively Recruiting
PhaseN/A
SponsorIstanbul Medipol University Hospital
Started2025-08-01
Est. completion2025-11-01
Eligibility
Age25 Years – 45 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07286760
Summary
Comparison of the Effects of MAT Pilates and MIHA Combined Exercise Programs on Pain, Quality of Life, Anxiety, and Endurance in Patients with Nonspecific Back Pain
Eligibility
Age: 25 Years – 45 YearsHealthy volunteers accepted
Inclusion Criteria: Being between 25 and 45 years of age Having had back pain for the last 3 months The back pain not being due to a structural, traumatic, infectious, or tumor-related cause (i.e., no specific cause has been identified) Not having any serious cardiovascular, neurological, or orthopedic conditions that would prevent participation in a physical exercise program Not having participated in a regular physical exercise program in the past 6 months Not having any contraindications to the use of a wearable EMS device (e.g., not having a pacemaker) Exclusion Criteria: The back pain is associated with a specific pathology (e.g., spinal stenosis, fracture, tumor, infection, etc.) Being within the first 6 months of pregnancy or postpartum History of neurological disease (e.g., multiple sclerosis, peripheral neuropathy, spinal cord injury, etc.) Having a pacemaker or other electronic device in the body Pre-existing intolerance to EMS
Conditions2
AnxietyLow Back Pain
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorIstanbul Medipol University Hospital
Started2025-08-01
Est. completion2025-11-01
Eligibility
Age25 Years – 45 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07286760